07:00 , Oct 9, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Inflammation Allergy Chemokine (CC motif) receptor-like 2 (CCRL2); chemerin Studies in mice suggest that inhibiting CCRL2 may be useful for preventing...